Financial Performance - Revenues for Q2 2025 totaled $1.53 billion, down from $1.71 billion year-over-year[4] - Net income decreased by 36% to $107.9 million, with diluted earnings per share declining 30% to $1.50[8] - Total revenues for the three months ended May 31, 2025, were $1,529,585, a decrease of 10.5% compared to $1,709,813 for the same period in 2024[17] - Net income for the three months ended May 31, 2025, was $107,883, representing a decline of 35.8% from $168,419 in 2024[17] - Homebuilding revenues for the six months ended May 31, 2025, were $2,911,757, down 7.8% from $3,159,638 in 2024[21] - Total pretax income for the six months ended May 31, 2025, was $281,740, down 28.8% from $395,784 in 2024[17] - Financial services pretax income for the six months ended May 31, 2025, was $15,687, a decrease of 36.9% from $24,840 in 2024[17] Home Delivery and Orders - Homes delivered decreased by 11% to 3,120 units compared to the previous year[4] - Homes delivered in the three months ended May 31, 2025, totaled 3,120, a decrease of 11.4% from 3,523 in the same period of 2024[23] - Net orders decreased by 13% to 3,460, with an ending backlog of 4,776 homes, down 27% year-over-year[8] - The backlog of homes as of May 31, 2025, was 4,776 homes valued at $2,288,231, down from 6,270 homes valued at $3,122,135 in 2024[23] Pricing and Margins - Average selling price increased slightly to $488,700, reflecting a 3% increase year-over-year[4] - The average selling price for homes in the three months ended May 31, 2025, was $488,700, an increase of 1.4% from $483,000 in 2024[21] - Homebuilding operating income was $131.5 million, with an operating income margin of 8.6%, down from 11.1%[4] - The adjusted housing gross profit margin for the three months ended May 31, 2025, was 19.7%, compared to 21.2% in 2024[25] Liquidity and Financial Position - Total liquidity stood at $1.19 billion, including $308.9 million in cash and cash equivalents[8] - Total assets as of May 31, 2025, were $7,017,596, an increase from $6,936,169 as of November 30, 2024[19] Stock and Guidance - The company repurchased $200 million of common stock at an average price of approximately $54 per share[3] - Guidance for full-year 2025 projects housing revenues between $6.30 billion and $6.50 billion[13] Taxation - The effective tax rate for the quarter was approximately 24.2%, compared to 23.8% in the previous year[8]

成分股孩之宝收涨2.87%，美妆公司e.l.f. Beauty涨2.72%，3M涨2.48%，蔻驰和耐克涨超1.6%。 百思买则收跌1.7%，安德玛A类股跌2.28%，Fluence Energy跌3.60%，Boot Barn跌4.20%。 周一（6月23日），"特朗普关税输家"指数涨0.64%，报95.80点。 ...

SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $250.0 million of shares of its common stock. All of the shares are being offered by Cidara. In connection with the proposed offering, Cidara expects to grant the underw ...

BOSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company” or “Plymouth”) today announced the acquisition of a 1.95-million-square-foot portfolio of industrial properties located across Columbus, Cincinnati, and Cleveland, Ohio for a total purchase price of $193.0 million. The 21-building portfolio comprises highly functional industrial assets with strong infill locations and desirable physical features including high clear heights, ample truck loading, updated ligh ...

Review of promising Myostatin and Activin E antibody data iBio to announce 3rd target in Astral Bio Collaboration Conference call Tuesday, June 24 at 8:30 a.m. ET SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the Company will host a conference call on Tuesday, June 24, at 8:30 a.m. ET to review its latest advances in obesity and cardiometabolic disease treatments and announce a third target in the AstralBio Col ...

CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit facility with Wells Fargo Bank, NA (“Wells Fargo”). This amendment modifies the current facility extending the term of the agreement to December 31, 2026 and modifies the borrowing capacity to $10 million. Mark A. Le Doux, Chairman and Chief Executive Offic ...

GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board."We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtroni ...

BETHESDA, MD, June 23, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ:AEI) ("AEI" or the "Company"), a diversified holding company principally engaged through its subsidiaries in the development of smart and sustainable home communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce that its Board of Directors has authorized a new stock repurchase program of up to $1,000,000 of the Company’s outstanding ...

ELKHART, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors has retired the Company’s existing share repurchase authorization which was set to expire on July 31, 2025 and re-authorized the Company to repurchase up to $400 million of its Common Stock. The Company may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means. The timing and amount of any transacti ...

Apple is reportedly in eleventh-hour negotiations with European regulators about changes to its App Store.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.As the Financial Times (FT) reported Monday (June 23), the t ...